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ABSTRACT 
Epilepsy is the most frequent neurodegenerative disease. It is a state of recurrent, spontaneous seizures. The present study was undertaken to evaluate the anti-convulsant 
activity of different extracts of Nerium oleander. Different doses of different extracts were assessed by using Maximal electro shock (MES) and Pentylene tetrazole (PTZ) 
induced convulsions for its anticonvulsant activity in a dose dependent manner. Anticonvulsant effect of the extracts were comparable to clinically used antiepileptic drugs 
Diazepam and phenytoin. The ethanolic and aqueous extracts showed significant activity in MES induced seizures by reducing tonic phase than compare to other extracts and 
control.The ethanolic extracts significantly delayed the onset of clonic and tonic convulsions induced by PTZ. 
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INTRODUCTION 
Epilepsy  is  a  neurological  disorder  that  affects  a  wide  range  of 
people throughout the world. It is a disorder of brain characterize by 
unpredictable  and  periodic  occurrence  of  a  transient  alteration  of 
behaviour due to the disordered, synchronous and rhythmic firing of 
populations of brain neurons 
1. Epilepsy is one of the most common 
afflictions of human beings with a prevalence rate of approximately 
1 % of the total population 
2. Incidence of epilepsy in developed 
countries is approximately 50 per 100,000 while that of developing 
country is 100 per 100,000 
3. It has been observed that the presently 
available  antiepileptic  drugs  are  unable  to  control  seizures 
effectively in as many as 25% of the patients 
4. The conventional 
antiepileptic  agents  like  phenytoin,  carbamazeipine  and  sodium 
valporate  carry  with  them  several  serious  side  effects  notably 
neurotoxicity 
5. As majority of antiepileptic drugs are consumed life 
long, concomitant administration of other drugs predisposes to the 
risk  of  drug  interaction.  However,  newer  antiepileptics  like 
gabapentin, vigabatrin, lamotrigine, etc are used supplemental to the 
conventional  agents 
1.  Thus,  it  is  necessary  to  investigate  for  an 
antiepileptic agent that is highly efficacious as well as safe in items 
of drug related toxicity. The aim of treating an epileptic is not only 
to abolish the occurrence of seizures but also to lead a self sustained 
life. The herbal medicines have wide therapeutic actions and safety 
profile.  This makes the herbal  therapies  to  be  successful.  One  of 
these can be the use of Nerium oleander (Family: Apocyanaceae) 
also known as kanner is an important shurb used against various 
disorders in indigenous system of medicine. The shrub commonly 
grows. It is in leaf all year, in flower from June to October. The 
flowers  are  hermaphrodite 
6.  Leaves  are  powerful  repellent.  A 
decoction of the leaves has been applied externally in the treatment 
of scabies and to reduce swellings. The leaves and the flowers are 
cardiotonic,  diaphoretic,  diuretic,  emetic,  expectorant.  It  has  also 
being reported to have antibacterial and anti diabetic  activities 
7,8. 
The Nerium oleander is an evergreen shrub growing to 4m by 4m. It 
is in leaf all year, in flower from June to October. The flowers are 
hermaphrodite 
6. The major components of it are oleander, neriin 
and  oleandrin.  The  bark  contains  toxic  glucosides,  rosaginin  and 
nerrin, volatile oil, fixed oil, etc 
9. In ancient ayurvedic literature, the 
plant  is  reported,  to  cure  conditions  of    various  skin  disorders, 
wound ,vomiting, burning sensation, wandering of the mind, cough . 
The  objective  of  present  study  investigated  the  anticonvulsant 
activity of the Pet.ether,ethanol and aqueous extracts using Maximal 
electroshock  induced  convulsion(MES)  model  and  
Pentylenetetrazole(PTZ) induced seizure model.  
MATERIALS AND METHODS 
Plant  material:  Nerium  oleander  leaves  were  collected  from  the 
rural area of Anandapur,Odisha. The plant was authenticated in the 
department of Bioscience, S.P.University , Anand, Gujarat, India. A 
voucher  specimen  of  plant  material  was  kept  at  School  of 
Pharmaceutical sciences, SOA University, Bhubaneswar, India for 
future reference. 
 Preparation of the extract: The leaves were shade dried at room 
temperature and finely powdered with help of a hand-grinding mill 
in such a way that the powdered material passed through sieve no 
40.  The  powered  of  leave  of  Nerium  oleander  was  extracted 
separately  by  continuous  hot  extraction  process  using  soxhlet 
apparatus with different solvents successively in increasing order of 
polarity  from  petroleum  ether,  alcohol  and  finally  fresh  aqueous 
extract 
10. The extracts were subjected to preliminary qualitatative 
chemical  analysis 
11.  The  suspensions  of  all  the  extracts  were 
prepared  by  using  0.5%  Tween  80  in  normal  saline  for  the 
experiment.  
Drugs  and  chemicals:  Phenytoin  sodium  (Sun  Pharmaceuticals 
India.Ltd, Halol. Gujarat. India, ), Diazepam (Ranbaxy Laboratories 
Ltd,  HMTD  textiles,  India),  Pentylene  tetrazole  (Sigma-Aldrich, 
St.Louis, MO63103, USA) were used for the study. All the solvents 
used for the extraction process are of Laboratory grade and they are 
purchased from local firms. Fresh drug solutions were prepared on 
the day of the experiment and administered orally (P.O.).  
Animals: Studies were carried out on Wistar albino rats of either sex 
weighing  150-220  g and  Albino  mice  weighing  between  18-22 g 
were  used  were  obtained  from  animal  house,  School  of 
Pharmaceutical  Sciences,  SOA  University,  Bhubaneswar,  Odisha, 
India. Animals were housed in groups of six in standard laboratory 
conditions  of  temperature  (25±2°C),  relative  humidity  (55  %), 
lighting (08:00–20:00 h) with food and water freely available. They 
were fasted 8 h before the experiments, but allowed free access to 
water. The study was approved by the Institutional Animal Ethical 
Committee.  
Acute toxicity studies (LD50): The acute oral toxicity study was 
carried  out  as  per  guidelines  set  by  Organisation  for  Economic 
Cooperation and Development (OECD). The median lethal dose of 
the  pet-ether  alcohol  and  aqueous  was  determined  by  orally 
administering the extracts in increasing dose levels of 0.1,0.2,0.5, 1, 
and 2 g/kg body weight to healthy adult albino mices of either sex. 
The  animals  will  be  observed  continuously  for  2  h  under  the 
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I.  Behavioural  profile:  Alertness,  restlessness,  irritability  and 
fearfulness.  
II.  Neurological  profile:  Spontaneous  activity,  reactivity,  touches 
response, pain response and gait.  
III. Autonomic profile: Defecation and urination.  
 After a period of 24 h they will be observed for any lethality or 
death (% of mortality).  
Assessment of anticonvulsant activity 
Maximal electroshock seizure (MES) test 
The animals  were divided into eleven  groups. Group 1 received 1 
ml/rat of saline, group 2 received 25 mg/kg of Phenytoin, groups 3, 
4 and 5 received 75,150 and 300 mg/kg of petroleum ether, groups 
6,  7,  8,  9,  10  and  11  received  alcohol  and  aqueous  extracts 
respectively of Nerium oleander. The saline and standard reference 
drug were administered 45 min before induction of seizure, where as 
the test extracts of Nerium oleander were administered 1 h before 
induction of seizure. To induce convulsions in the control and drug 
treated  animals,  the  maximal  (tonic  hind  limb  extension) 
electroshock seizure (MES) was carried out via copper electrodes 
(introduced  bilaterally  into  the  ears)  with  the  apparatus  Electro- 
convulsometer (Techno), using a fixed current 150 mA in rats for 
0.2 s. The tonic extension of the hind limbs (extensor phase) and 
mortality were recorded 
12, 13.  
Pentylenetetrazole (PTZ) Induced Convulsions: 
In Pentylene tetrazole (PTZ) induced convulsion model ,the animals 
were divided into 8 groups of 6 animals each. Group I served as 
control. Group II served as standard group, and was treated  with 
Diazepam (4 mg/kg) and pentylenetetrazol (70 mg/kg) i.p. Group III 
and IV were treated with alcoholic extract (150and 300mg/kg body 
weight  respectively)  orally  and  pentylenetetrazol  (70  mg/kg)  i.p. 
Group  V  and  VI  were  treated  with  aqueous  extract  (150    and 
300mg/kg body weight) orally and pentylenetetrazol (70 mg/kg) i.p. 
Group VII and VIII were treated with pet.ether extract (150  and 
300mg/kg body weight) orally and pentylenetetrazol (70 mg/kg) i.p. 
The standard and control groups received diazepam (4mg/kg, ip) and 
1%  tween  80  (10  ml/kg,  orally)  respectively.  PTZ  was  injected 
intraperitoneally to the extract treated and control groups after one 
hour and diazepam treated group after 30 mins. The animals were 
then individually placed in trays and observed immediately. After 
PTZ injection for a period of 30 minutes. The latency and duration 
of myoclonic jerks as well as incidence of seizures were recorded. 
Time taken for death/recovery was also noted 
14. 
RESULTS AND DISCUSSION 
Epilepsy is one of the most common serious neurological conditions. 
Seizure  refers  to  a  transient  alteration  of  behaviour  due  to 
disordered, synchronous and rhythmic firing of populations of brain 
neurons 
15; the frequency and importance of epilepsy can hardly be 
overstated  from  the  epidemiologic  studies.  However,  in  most 
studies, the overall incidence of epilepsy in developed societies has 
been found to be around 50 cases per 100,000 persons per year, and 
rises steeply in older age 
16.  
In  pentelenetetrazole-induced  seizure  model,  N.oleander  150  and 
300 mg/kg produced significant (p<0.01) reduction in duration of 
convulsion  and  was  comparable  to  that  produced  by 
diazepam(Table-2) . In the maximum electroshock induced seizure 
model,  N.oleander  150  and  300  mg/kg  and  diazepam  showed 
significant  (p<0.01)  reduction  in  duration  of  convulsion,  but 
N.oleander 75 mg/kg did not exhibit anticonvulsant effect(Table-1). 
The anticonvulsant activity of N.oleander at various dose levels viz, 
150 and 300 mg/kg p.o. were studied by the pentelenetetrazole and 
maximum electroshock-induced seizure models. The most popular 
and widely used animal seizure models are the traditional maximum 
electroshock-induced  seizure  and  pentelenetetrazole  tests. 
Prevention of seizures induced by pentelenetetrazole in laboratory 
animals is the most commonly used preliminary screening test for 
characterizing  potential  anticonvulsant  drugs.  The  maximum 
electroshock-induced seizure test is considered to be a predictor of 
likely therapeutic efficacy against generalized tonic-clonic seizures. 
By contrast, the pentelenetetrazole test represents a valid model for 
human  generalized  myoclonic  and  also  absence  seizures.  Other 
chemoconvulsant models for primary generalized seizures include 
by bicuculine (GABAA receptor antagonized), strychnine (glycine 
receptor  antagonist)  and  aminophylline  (adenosinereceptor 
antagonist). The pentelenetetrazole assay has been used primarily to 
evaluate antiepileptic drugs. However, it has been shown that, most 
anxiolytic  agents  are  also  able  to  prevent  or  antagonize 
metrazoleinduced  convulsion.  Generally,  compounds  with 
anticonvulsant  activity  in  the  petitmal  epilepsy  are  effective  in 
pentelenetetrazole-induced  seizure  model 
17.  Data  from  the  study 
showed  that  the  tonic  convulsion  produced  by  pentelenetetrazole 
was  significantly  delayed  by  N.oleander.  The  preliminary 
phytochemical  investigation  of  different  extracts  of  N.oleander 
revealed  the  presence  of  carbohydrate,  glycosides,  flavonoid, 
triterpenoid and steroids. The result of the current study indicate that 
the  ethanol,  aqueous  and  pet.ether  extracts  of  N.oleander  has 
delayed  the  onset  of  convulsions  induction,  and  was  able  to 
decreased the durations of hind limb extension, clonus and stupor 
phases of MES induced convulsion as compared to control . The 
standard  drug  phenytoin  in  a  dose  of  25  mg/kg  body  weight 
provided  100  %  protection  and  also  significantly  reduced  the 
duration  of  stupor  when  compared to  control.  In  other  words  the 
alcoholic and aqueous extracts is able to decreased the duration of 
hind limb extension (extensor phase), clonus and also the duration of 
stupor phase, which indicate the alcoholic extract does. 
The data also show that diazepam antagonize the pentelenetetrazole-
induced convulsion. According to be Sarro et al, pentelenetetrazole 
may be exerting its convulsive effect by inhibiting the activity of 
gamma  amino  butyric  acid  (GABA)  at  GABAA  receptors 
18  the 
major inhibitory neurotransmitter which is implicated in epilepsy. 
The enhancement and inhibition of the neurotransmission of GABA 
will  attenuate  and  enhance  convulsion  respectively 
19,20  . 
Phenobarbitone  and  diazepam  have  been  shown  to  exert  their 
antiepileptic effects by enhancing the GABA-mediated inhibition in 
the brain 
21. It is possible that diazepam and N.oleander antagonize 
pentelenetetrazole  convulsion  in  this  study  by  enhancing  GABA 
neurotransmission. Since the N.oleander delayed the occurrence of 
pentelenetetrazole-induced convulsion, it is probable that it may be 
interfering  with  GABA  aminergic  mechanism(s)  to  exert  its 
anticonvulsant  effect.The  maximal  electroshock  test  is  the  most 
widely used animal model in antiepileptic drug discovery, because 
seizure  induction is  simple and the  predictive  value  for  detecting 
clinically effective antiepileptic is high 
22. The maximal electroshock 
test identifies agents with activity against generalized tonic clonic 
seizures    using  clinically  established  antiepileptic  drugs 
22.  The 
pharmacology of acute maximal electroshock dose not differs from 
the  pharmacology  of  generalized  tonic-clonic  seizures  in  genetic 
models  with  choronic  epilepsy,  eg.  Audiogenicseizure  susceptible 
mice and rats or epileptic gerbils 
23. In addition to identifying drug 
activity against generalized tonic-clonic seizures, it has often been 
proposed that the maximal electroshock test predicts anticonvulsant 
drug effects against partial seizures. The anticonvulsant activity of 
N.oleander  300  mg/kg,  in  maximal  electroshock  model  indicates 
that N.oleander might precipitate the tonic and clonic seizures. 
Since inhibition of the MES test predicts activity against generalized 
tonic-clonic  and  cortical  focal  seizures  so  activity  against  MES 
induced seizures suggests that the ethanolic and aqueous extracts of 
N.oleander leaves are useful in suppressing generalized tonic-clonic 
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an  action  at  distinct  sites  of  this  synopsis 
24.  PTZ  test  predicts 
activity against absence seizures. Since PTZ is a GABAA receptor 
antagonist,  the  ethanolic  and  aqueous  extracts  may  be  acting  by 
increasing GABA concentration in the brain. 
CONCLUSION 
The  data  obtained  in  present  study  indicated  that  ethenolic  and 
aqueous  extracts  of  N.oleander  may  be  said  to  exert  its 
anticonvulsant effect against MES- induced seizures via non-specific 
mechanisms.  However  more  extensive  study  on  mechanism  of 
action and safety of the plant as medicinal remedy has to be carried 
out. The probable mode of action may be due to GABAaminergic 
mediation, glycine inhibitory mechanism and inhibit the electrical 
kindling effect. In conclusion, The precise mechanisms of possible 
anticonvulsant effect of plant extracts  are not clear. Further research 
is in progress to isolate the compound responsible for this activity. 
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Table-1: Effect of  leaves of N.Oleander against MES  induced  convulsions 
Sl.No  Treatment  Time (Sec) in various phases of convulsions (MEAN±SEM) 
  Drug  Dose (mg/kg)  Flexon  extensor  Clonus  Stuper  Recovery/Death 
1  Normal Saline  5 ml/kg  3.2±0.15  17.33±1.7  16.6±2.2  102.5±2.8  Recovery 
2  Phenytoin  25  1.4±0.12***  0  31.35±0.23  66.86±0.32***  Recovery 
3 
 
 
PEE 
75  3.23±0.16  17.33±1.68  17.83±2.42  99.83±2.83  Recovery 
150  1.48±0.13**  16.33±1.38  23.51±2.29  94.16±9.12*  Recovery 
300  1.35±0.09***  14.66±1.2**  24.05±1.89  62±2.08***  Recovery 
4 
 
ALE  75  2.83±0.25*  16.16±1.6  17.16±2.18  112±2.91  Recovery 
150  1.58±0.16**  13.5±1.17**  15.01±1.26  90.16±6.76**  Recovery 
300  1.2±0.05***  9.48±0.48***  12.16±1.37  70.16±4.03**  Recovery 
5  AQE  75  3.81±0.17  21.16±1.79  27.66±2.34  114.5±2.65  Recovery 
150  2.65±0.27**  15.8±1.9*  22.18±1.58  97.8±5.05*  Recovery 
300  2.53±0.18**  11.5±0.76**  18.96±1.27  64.5±3.73***  Recovery 
Values are expressed as MEAN±SEM                                                    one way Anova followed by Dunnets ‘t’ test 
Note: n=6 in each group, *P<0.05,**P<0.01,***P<0.001 
 
Table-2: Effect of  leaves of N.Oleander against PTZ induced  convulsions 
Sl.No  Treatment  Onset of clonus  Onset of tonic  % Protection 
Drug  Dose (mg/kg) 
1  Normal Saline  5 ml/kg  84.16±3.6  381.6±7.36  00 
2  Diazepam  5  0.7±0.35  Ab  100 
3 
 
 
PEE 
150  122.6±7.37*  459.6±20.43**  50 
300  147.16±10.06**  570.83±49.58***  67 
4 
 
ALE  150  221.8±6.2***  540±30.24  67 
300  273.6±6.2***  764.6±32.89  84 
5  AQE  150  124±4.7**  420.6±17.58**  50 
300  153±5.26**  531.6±26.8**  84 
Values are expressed as MEAN±SEM                                                    one way Anova followed by Dunnets ‘t’ test 
Note: n=6 in each group, *P<0.05,**P<0.01,***P<0.001 
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